Can brain stimulation sharpen Decision-Making in Parkinson's?

NCT ID NCT01845883

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study investigates how the brain makes decisions when visual information is uncertain, focusing on the roles of the basal ganglia and cerebellum. Researchers will compare healthy adults with patients who have Parkinson's disease, dystonia, or cerebellar damage, and will test whether deep brain stimulation (DBS) or certain medications affect decision-making performance. Participants perform a visual task while their brain activity is influenced by DBS (on/off) or medication status. The goal is to understand the neural mechanisms behind perceptual choices under uncertainty, which could inform future treatments for these conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Deep Brain Stimulation (DBS) - a procedure that uses implanted electrodes to deliver electrical pulses to specific brain areas.
What this could lead to
If successful, this research could clarify how the basal ganglia and cerebellum support decision-making under uncertainty, potentially guiding future treatments for Parkinson's disease, dystonia, and ataxia.
What could go wrong
This is an early-stage observational study with a small number of participants, so findings may not apply broadly. DBS carries risks such as infection, bleeding, or device-related complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATAXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Neuroscience Research Building

    Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.